A Novel HER2-positive Breast Cancer Phenotype Arising From Germline TP53 Mutations

Journal of Medical Genetics - United Kingdom
doi 10.1136/jmg.2010.078113
Full Text
Abstract

Available in full text

Categories
Genetics
Date
Authors
Publisher

BMJ

Related search

Breast Cancer Phenotype in Women With TP53 Germline Mutations: A Li-Fraumeni Syndrome Consortium Effort

Breast Cancer Research and Treatment
Cancer ResearchOncology
2012English

Germline TP53 and MSH6 Mutations Implicated in Sporadic Triple-Negative Breast Cancer (TNBC): A Preliminary Study

Human Genomics
Molecular MedicineDrug DiscoveryGeneticsMolecular Biology
2019English

Frequency, Impact and a Preclinical Study of Novel ERBB Gene Family Mutations in HER2-positive Breast Cancer

Therapeutic Advances in Medical Oncology
Oncology
2018English

Novel Approaches to Target HER2-positive Breast Cancer: Trastuzumab Emtansine

Cancer Management and Research
Oncology
2016English

Novel Germline PALB2 Truncating Mutations in African American Breast Cancer Patients

Cancer
Cancer ResearchOncology
2011English

Novel HER2 Aptamer Selectively Delivers Cytotoxic Drug to HER2-positive Breast Cancer Cells in Vitro

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2012English

TP53 Mutations Promote Immunogenic Activity in Breast Cancer

Journal of Oncology
Oncology
2019English

Neuromedin U Alters Bioenergetics and Expands the Cancer Stem Cell Phenotype in HER2-positive Breast Cancer

International Journal of Cancer
Cancer ResearchOncology
2017English

Targeted Therapy for HER2 Positive Breast Cancer

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy